ストックスクリーナーアプリを入手
543.32
3.50%
18.36
前日終値:
$524.96
開ける：
$525.36
24時間の取引高:
3.05M
Relative Volume:
1.27
時価総額：
$205.16B
収益：
$43.21B
当期純損益:
$6.58B
株価収益率:
31.45
EPS:
17.2769
ネットキャッシュフロー:
$6.17B
1週間 パフォーマンス:
+17.03%
1か月 パフォーマンス:
+12.13%
6か月 パフォーマンス:
+15.59%
1年 パフォーマンス:
-9.59%
1日の値動き範囲:
$525.36
$545.44
1週間の範囲:
$456.67
$545.44
52週間の値動き範囲:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-11 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 開始されました | William Blair | Outperform |
| 2025-07-24 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Top Companies in Biobanking MarketThermo Fisher Scientific - openPR.com
Can Thermo Fisher Scientific Inc. recover in the next quarterMarket Rally & Weekly Stock Performance Updates - newser.com
Jim Cramer on Thermo Fisher: “They Really Got Hurt By COVID” - MSN
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MSN
Vaxcyte’s Strategic Moves: Impact on PCVX - StocksToTrade
Why Thermo Fisher (TMO) Stock Is Trading Up Today - TradingView
Metagenomics Market Size Booms at 13.55% CAGR, Projects to Climb USD 8.39 Billion by 2034 - GlobeNewswire Inc.
Vector Purification Market Research, Industry Trends & Global Forecasts, 2035, Profiles of Agilent, BIA Separations, Bio-Rad, BioVision, Cytiva, Merck, Sartorius, Takara Bio, Thermo Fisher ScientificResearchAndMarkets.com - Business Wire
KeyBanc maintains Sector Weight rating on Thermo Fisher stock amid mixed segment performance - Investing.com
Thermo Fisher ups the accuracy on elemental analysis - International Mining
Cell and Gene Therapy Manufacturing Services Market Trends & - openPR.com
Where is Thermo Fisher Scientific (TMO) Headed According to Analysts? - MSN
DPIIT inks MoU with Thermo Fisher Scientific to aid 500 biotech startups - Medical Buyer
Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel - News-Medical
Thermo Fisher Scientific announces pricing of senior notes - Medical Buyer
Will Thermo Fisher Scientific Inc. (TN8) stock return to pre crash levelsJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
Will Thermo Fisher Scientific Inc. stock outperform growth indexesQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
BenchSci Partners with Thermo Fisher to Enhance R&D Productivity with AI Tools - SynBioBeta
Q&A: Thermo Fisher’s Luke Wilson on hitting 100% dose delivery with patient-centric supply - drugdiscoverytrends.com
Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher's N.C. production facility - Fierce Pharma
November 14th Options Now Available For Thermo Fisher Scientific (TMO) - Nasdaq
Can Thermo Fisher (TMO) Balance Biomanufacturing Expansion and AI Ambitions to Shape Its Long-Term Edge? - Yahoo Finance
Hans Scientific invests $2B in US to avoid tariffs; Thermo Fisher inks up to $1B contract - Endpoints News
Vaxcyte teams up with Thermo Fisher to ensure future vaccine production - MSN
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday October 22 2025 - MarketScreener
Barclays Adjusts Price Target on Thermo Fisher Scientific to $585 From $550, Maintains Overweight Rating - MarketScreener
Thermo Fisher Scientific Insiders Sold US$2.0m Of Shares Suggesting Hesitancy - 富途牛牛
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025 - BioSpace
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub - BioSpace
Bernstein Reaffirms Outperform Rating on Thermo Fisher (TMO) After Investor Roadshow - Yahoo Finance
DPIIT, Thermo Fisher Scientific tie up to boost India’s biotech startup ecosystem - Social News XYZ
Thermo Fisher Scientific gibt Forschungskooperation mit AstraZeneca BioVentureHub bekannt - The Joplin Globe
Thermo Fisher Scientific annonce un partenariat de recherche et développement avec l'AstraZeneca BioVentureHub - Enidnews.com
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism - FinancialContent
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher’s Strategic Moves: Surging Ahead? - StocksToTrade
Thermo Fisher (TMO) Stock Trades Up, Here Is Why - Yahoo Finance
Thermo Fisher Scientific Hits Day High with 4.48% Surge in Stock Price - Markets Mojo
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe - MarketScreener
Thermo Fisher Scientific (TMO) Rises After Completing $2.5 Billi - GuruFocus
Thermo Fisher Scientific (TMO) Rises Amid Positive Market Sentim - GuruFocus
Thermo Fisher Scientific to hold earnings conference call on Wednesday, October 22 - MarketScreener
Leading Scientific Instrument Maker Thermo Fisher Scientific Announces Q3 2025 Earnings Date and Conference Call - Stock Titan
Bernstein reiterates Outperform rating on Thermo Fisher stock By Investing.com - Investing.com UK
GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire
Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown - Sahm
Thermo Fisher Scientific Prices $2.5 Billion Worth of Debt Offerings - MarketScreener
Product Management Specialist II Job at Thermo Fisher Scientific- Apply Now - BioTecNika
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - BioSpace
Thermo Fisher Scientific (TMO) Launches $2.5 Billion Senior Notes Offering - GuruFocus
Thermo Fisher Scientific prices $2.5B senior notes - MSN
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
2.22%
0.42%
大文字化:
|
ボリューム (24 時間):